#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prader-Willi syndrome Acquired C1 inhibitor deficiency Thromboangiitis obliterans Alexander disease Chronic cutaneous lupus erythematosus Dementia with Lewy bodies Propionic acidaemia Leukodystrophy Nasopharyngeal cancer Ovarian cancer stage III Neuropathic arthropathy Postprandial hypoglycaemia Amyotrophic lateral sclerosis gene carrier Skin cancer Cervix carcinoma More trials…

    Learn about Rare Diseases

    Noonan syndrome – Trials in Disease Haemophilia A with anti factor VIII Lymphangioma – Treatment Basal cell naevus syndrome – Life with Disease Amyotrophic lateral sclerosis – Treatment Angiosarcoma non-metastatic – Trials in Disease Systemic mastocytosis – Trials in Disease Langerhans’ cell histiocytosis – Trials in Disease Thrombotic thrombocytopenic purpura – Trials in Disease Undifferentiated sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lanreotide Sevoflurane Ucart20X22 Leucine Deucravacitinib Ly3473329 Povidone, Iodinated Vusolimogene Oderparepvec Bendamustine Imetelstat Sodium Cabergoline Wt1 Mrna Dc Mk-0616 CHLOROQUINE PHOSPHATE Ptc518 Linrodostat Mesilate Estriol GSKVX000000030918 Soft Paraffin And Fat Products OMTX705 More therapies…

    Learn about Your Condition

    Pancreatic failure Colorectal cancer stage III Synovitis Bile duct cancer Primary hyperoxaluria Mastocytosis Mitral valve prolapse Peripheral artery stenosis Hysterectomy Normal pressure hydrocephalus Albuminuria Somatic symptom disorder Anal fistula Colon cancer HER2 positive gastric cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endometrial cancer

  • A Study of Inavolisib for Patients with Advanced Endometrial Cancer Who Have PIK3CA Gene Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    • Inavolisib
    Italy

  • A Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zanidatamab
    Spain

  • A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Endometrial cancer recurrent
    Investigated Drugs:
    • Db-1303
    • Docetaxel
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia Denmark Finland France +9

  • Study of dostarlimab treatment before surgery in patients with stage II-III endometrial cancer with specific genetic markers

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer stage II
    • Endometrial cancer stage III
    • Endometrial cancer
    Investigated Drugs:
    • Dostarlimab
    Spain

  • Study of MK-5684 compared to standard therapy in patients with breast cancer, ovarian cancer, or endometrial cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Ovarian cancer
    • Breast cancer
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Hydrocortisone Acetate
    • Medroxyprogesterone Acetate
    Spain

  • Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Rilvegostomig
    • Carboplatin
    • Docetaxel
    Austria Belgium Denmark Finland France Germany +7
Previous Page
1 2 3 4 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!